Table 5.
The molecular subtypes of 51 cases with an invasive carcinoma component, according the IHC surrogate markers, calculated and classified in the manner of 2011 St. Gallen recommendations
Subtypes | Luminal A | Luminal B HER2-negative | Luminal B HER2-positive | HER2-enriched | TPN | |
---|---|---|---|---|---|---|
Sum of all n = 51 |
n = 15 | n = 7 | n = 9 | n = 18 | n = 2 | |
Percentage of all | 29% | 14% | 18% | 35% | 4.0% | |
pT | ||||||
pTmic | 5 (33%) | 3 (33%) | 7 (44%) | 1 (50%) | ||
pT1a | 2 (13%) | 3 (43%) | 4 (45%) | 10 (44%) | 1 (50%) | |
pT1b | 8 (54%) | 4 (57%) | 2 (22%) | 1 (12%) |